HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeremy Grayson Selected Research

1-methylpropyl-2-imidazolyl disulfide

1/2013Effects of the thioredoxin-1 inhibitor PX-12 on blood-brain barrier permeability in the early stage of focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeremy Grayson Research Topics

Disease

4Brain Ischemia (Cerebral Ischemia)
01/2015 - 01/2012
1Infarction (Infarctions)
01/2015
1Neoplasms (Cancer)
01/2013

Drug/Important Bio-Agent (IBA)

1DexmedetomidineFDA Link
01/2015
1Hypnotics and Sedatives (Sedatives)IBA
01/2015
1Oxygen (Dioxygen)IBA
09/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1ThioredoxinsIBA
01/2013
11-methylpropyl-2-imidazolyl disulfideIBA
01/2013
1Antineoplastic Agents (Antineoplastics)IBA
01/2013
1Cannabinoid Receptor AgonistsIBA
01/2012
1RimonabantIBA
01/2012
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2012